WHO Mental Health Gap Action Programme (mhGAP)
Mental, neurological, and substance use disorders are common in all regions of the world, affecting every community and age group across all income countries. While 14% of the global burden of disease is attributed to these disorders, most of the people affected - 75% in many low-income countries - do not have access to the treatment they need.
The WHO Mental Health Gap Action Programme (mhGAP) aims at scaling up services for mental, neurological and substance use disorders for countries especially with low- and middle-income. The programme asserts that with proper care, psychosocial assistance and medication, tens of millions could be treated for depression, schizophrenia, and epilepsy, prevented from suicide and begin to lead normal lives– even where resources are scarce.
mhGAP Forum, 9 – 10 October 2017, WHO, Geneva
The two days of activities in the Forum will provide an opportunity for a diverse group of stakeholders to discuss a variety of themes, all related to the implementation of WHO’s Mental Health Action Plan 2013-2020. The Forum will also discuss specific commitments from partners towards implementing the Action Plan. There will also be time available for informal networking.
Participation by invitation only. For more information contact firstname.lastname@example.org
Several resources are available to help reduce the mental health treatment gap and to enhance the capacity of Member States to respond to the large burden of mental, neurological and substance use disorders.
mhGAP Intervention Guide - Version 2.0
mhGAP Intervention Guide
- mhGAP Intervention Guide e-version
- mhGAP module Assessment Management of Conditions Specifically Related to Stress
- mhGAP Evidence Resource Centre
- mhGAP WHO-EU joint project in Ethiopia and Nigeria
- mhGAP publications
mhGAP Forum 2016 report
- Previous mhGAP Forum reports